Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery
Key facts
- Who runs it
- Democritus University of Thrace
- Where
- Greece1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 300 people, planned
- Started
- 1 May 2026
- Expected to end
- 1 May 2027
- Type of study
- Observational, 3 groups
- Treatments tested
- Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
- Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
- Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)
- Record updated
- 12 May 2026
Who can take part
- Age
- 45 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Diagnosis of senile cataract with stage 2 or 3 nuclear opalescence according to the - Lens Opacities Classification System III (LOCS-3) grading scale
Who cannot take part
- Former incisional surgery
- Former diagnosis of corneal disease
- Autoimmune diseases
- Mental diseases
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Cataract or dry eye
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The primary objective of this study is the assessment of three tear substitute formulations in terms of postoperative discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.
The 3 groups in the trial
- Study Group 1
Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
Treatment: Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
- Study Group 2
Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
Treatment: Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
- Study Group 3
Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)
Treatment: Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery: A Non- Interventional, Observational Study
- Criteria questions
- Built from NCT07581548, who can take part
- Record updated
- 12 May 2026